Tora S. Solheim

Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Journal: Clinical and translational radiation oncology

Published: May 03, 2026

Linking Inflammation to Reduced Food Intake in Advanced Cancer: A Prospective Observational Study.

Linking Inflammation to Reduced Food Intake in Advanced Cancer: A Prospective Observational Study.

Journal: Current oncology (Toronto, Ont.)

Published: February 13, 2026

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Journal: Clinical and translational radiation oncology

Published: December 09, 2025

Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical Landscape.

Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical Landscape.

Journal: Current oncology (Toronto, Ont.)

Published: October 17, 2025

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Journal: NPJ precision oncology

Published: October 14, 2025

Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation.

Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation.

Journal: Current oncology (Toronto, Ont.)

Published: October 06, 2025

Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trial.

Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trial.

Journal: Neuro-oncology advances

Published: July 23, 2025

Potential impact of [18F]-FACBC PET in radiotherapy target definition of glioma.

Potential impact of [18F]-FACBC PET in radiotherapy target definition of glioma.

Journal: Radiation oncology (London, England)

Published: May 29, 2025

Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani et al.-The Authors' Reply.

Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani et al.-The Authors' Reply.

Journal: Journal of cachexia, sarcopenia and muscle

Published: May 13, 2025

Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.

Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.

Journal: Journal of neuro-oncology

Published: May 06, 2025

A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: a prospective observational study.

A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: a prospective observational study.

Journal: Journal of circulating biomarkers

Published: February 27, 2025

Emergency palliative cancer care: anxiety and midazolam.

Emergency palliative cancer care: anxiety and midazolam.

Journal: BMC palliative care

Published: December 20, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026